ReviewJournal of clinical medicine2018

New Molecular Technologies for Minimal Residual Disease Evaluation in B-Cell Lymphoid Malignancies.

Irene Dogliotti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.